Showing 1,601 - 1,620 results of 113,971 for search '(( 2 mean decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 1601
  2. 1602
  3. 1603

    Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…(B) HEI-193 grown in PDGF media were treated with 0, 3, 5, 10 or 20 µM nilotinib up to 5 days. Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
  4. 1604
  5. 1605
  6. 1606

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…<p>Virus replication was determined by measuring HIV-1 p24 levels in the culture supernatants in PBMC from six individual donors at day 7 post-infection performed in duplicate. Blocking TNF (at 2 ug/ml or 5 ug/ml) or IL-6 (5 ug/ml) significantly decreased virus replication (*, p<0.05) as compared to the same concentrations of an IgG<sub>1</sub> control antibody. …”
  7. 1607

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. F. Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. …”
  8. 1608
  9. 1609
  10. 1610
  11. 1611

    <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae have decreased <i>MtnB</i>:<i>EYFP</i> expression. by Christopher D. Richards (4246669)

    Published 2017
    “…Band intensity for <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae was calculated relative to controls and averaged over multiple western blots (values are represented as the mean ± SD, N ≥ 3). C) There is an approximate 5 fold decrease in <i>MtnB</i>:<i>EYFP</i> expression in <i>Zip88E</i><sup><i>Δ/Δ</i></sup> larvae compared to controls when raised on basal media. …”
  12. 1612
  13. 1613
  14. 1614
  15. 1615
  16. 1616
  17. 1617

    Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist. by Masahiko Kanehira (183764)

    Published 2012
    “…Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
  18. 1618

    AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production. by Maria Alícia Carrillo-Sepúlveda (406779)

    Published 2013
    “…Data are expressed as mean ± SD (n = 5 per group for A and B; n = 4 per group for C and D; *p<0.05 <i>vs.…”
  19. 1619
  20. 1620